Position
Chief Medical Officer
Company
Haya Therapeutics
LausanneBiotechnologyHealth CareScience And EngineeringDescription
HAYA Therapeutics, SA has announced the appointment of Jordan Shin, MD, PhD as Chief Medical Officer. Dr Shin, a veteran in the cardiovascular and lung spaces with translational experience in genetic medicines, will play a key role in advancing HAYA’s therapeutics, including lead candidate HTX-001 for non-obstructive hypertrophic cardiomyopathy, to the clinic and to patients.
Quick answer
HAYA Therapeutics Appoints Jordan Shin as Chief Medical Officer (CMO) (September 11, 2024). Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Who is the new Chief Medical Officer at Haya Therapeutics?
- Haya Therapeutics named Jordan Shin Chief Medical Officer, announced September 11, 2024.
- What did Haya Therapeutics announce on September 11, 2024?
- HAYA Therapeutics, SA has announced the appointment of Jordan Shin, MD, PhD as Chief Medical Officer. Dr Shin, a veteran in the cardiovascular and lung spaces with translational experience in genetic medicines, will play a key role in advancing HAYA’s therapeutics, including lead candidate HTX-001 for non-obstructive hypertrophic cardiomyopathy, to the clinic and to patients.
- What does Haya Therapeutics do?
- HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states...
- Where is Haya Therapeutics based?
- Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Which similar companies made leadership changes around the same time?
- Unlearn (September 11, 2024), Viome (September 10, 2024), Ray Therapeutics (September 16, 2024) and Electra Therapeutics (August 29, 2024) also announced leadership changes within 45 days of Haya Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Unlearn Appoints Steve Herne as CEO, Charles Fisher as Chief Scientist (September 11, 2024)
- Viome Appoints Kal Raman as Chief Operating Officer to Spearhead Initiatives (September 10, 2024)
- Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer (September 16, 2024)
- Electrasteel Inc. Appoints James Rutland as Chief Financial Officer and Steve MacManus as Vice President of Engineering (August 29, 2024)
- Freenome Establishes Interim Office of the CEO with Riley Ennis, Co-founder, Taking Lead Role (September 25, 2024)
- Wheeler Bio Appoints Patrick Lucy as Chief Executive Officer (October 9, 2024)
Who to call at Haya Therapeutics, and when
A new leader at Haya Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Haya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haya Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Haya Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.